AstraZeneca (LON:AZN) PT Lowered to £125
AstraZeneca (LON:AZN – Free Report) had its price objective decreased by Jefferies Financial Group from £130 ($164.20) to £125 ($157.89) in a research note released on Monday morning, MarketBeat Ratings reports. Jefferies Financial Group currently has a buy rating on the biopharmaceutical company’s stock. Several other research firms have also recently commented on AZN. JPMorgan […]
More Stories
Insider Selling: Coinbase Global, Inc. (NASDAQ:COIN) Director Sells 11,421 Shares of Stock
Coinbase Global, Inc. (NASDAQ:COIN) Director Frederick Ernest Ehrsam III sold 11,421 shares of the stock in a transaction on Monday,...
Darden Restaurants, Inc. (NYSE:DRI) CFO Sells $1,313,399.88 in Stock
Darden Restaurants, Inc. (NYSE:DRI – Get Free Report) CFO Rajesh Vennam sold 7,228 shares of the stock in a transaction...
China Resources Power Holdings Company Limited (OTCMKTS:CRPJY) Short Interest Update
China Resources Power Holdings Company Limited (OTCMKTS:CRPJY – Get Free Report) saw a large increase in short interest in December....
RIV Capital Inc. (OTCMKTS:CNPOF) Short Interest Update
RIV Capital Inc. (OTCMKTS:CNPOF – Get Free Report) saw a large increase in short interest in December. As of December...
Scott H. Keeney Sells 12,013 Shares of nLIGHT, Inc. (NASDAQ:LASR) Stock
nLIGHT, Inc. (NASDAQ:LASR – Get Free Report) CEO Scott H. Keeney sold 12,013 shares of the business’s stock in a...
Insider Selling: Getty Images Holdings, Inc. (NYSE:GETY) CFO Sells 12,342 Shares of Stock
Getty Images Holdings, Inc. (NYSE:GETY – Get Free Report) CFO Jennifer Leyden sold 12,342 shares of the firm’s stock in...